Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BLLN | Atay Oguzhan | Chairman and CEO | 28.10.2026 | Verkauf | 118,00 | 2.667 | 314.706 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.10.2026 | Verkauf | 118,00 | 8.333 | 983.294 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 26.10.2026 | Verkauf | 1,12 | 21.368 | 23.911 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 19.10.2026 | Verkauf | 0,924 | 27.775 | 25.664 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 15.10.2026 | Verkauf | 102,78 | 133 | 13.669 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 15.10.2026 | Verkauf | 101,79 | 980 | 99.751 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 15.10.2026 | Verkauf | 100,60 | 1.276 | 128.369 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 15.10.2026 | Verkauf | 99,84 | 1.861 | 185.809 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 15.10.2026 | Verkauf | 98,43 | 900 | 88.590 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.10.2026 | Verkauf | 98,00 | 2.667 | 261.366 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.10.2026 | Verkauf | 99,00 | 100 | 9.900 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.10.2026 | Verkauf | 98,32 | 3.083 | 303.120 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 12.10.2026 | Verkauf | 0,975 | 25.098 | 24.471 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 12.10.2026 | Verkauf | 97,61 | 2.667 | 260.326 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 12.10.2026 | Verkauf | 96,39 | 1.521 | 146.613 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 12.10.2026 | Verkauf | 94,61 | 3.869 | 366.059 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 12.10.2026 | Verkauf | 93,65 | 6.763 | 633.335 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 12.10.2026 | Verkauf | 93,05 | 2.553 | 237.546 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 12.10.2026 | Verkauf | 91,57 | 1.961 | 179.571 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 05.10.2026 | Verkauf | 1,02 | 24.272 | 24.660 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 110,09 | 100 | 11.009 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 109,14 | 1.829 | 199.625 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 108,53 | 4.916 | 533.554 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 107,47 | 2.200 | 236.435 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 106,10 | 400 | 42.442 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 105,56 | 555 | 58.585 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 110,08 | 20 | 2.202 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 109,00 | 2.921 | 318.398 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 108,39 | 4.284 | 464.356 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 107,20 | 1.909 | 204.635 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 05.10.2026 | Verkauf | 105,90 | 866 | 91.710 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 05.10.2026 | Verkauf | 105,15 | 1.417 | 148.998 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 170,02 | 2 | 340 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 169,36 | 14 | 2.371 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 168,21 | 12 | 2.019 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 167,59 | 78 | 13.072 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 166,44 | 50 | 8.322 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 165,49 | 120 | 19.859 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 164,64 | 24 | 3.951 | Form 4 |
| BLTE | Scholl Hendrik Peter | Chief Medical Officer | 01.10.2026 | Verkauf | 163,63 | 200 | 32.725 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 28.09.2026 | Verkauf | 1,10 | 22.523 | 24.820 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Verkauf | 120,64 | 2.666 | 321.626 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 28.09.2026 | Verkauf | 120,64 | 8.333 | 1.005.293 | Form 4 |
| BLSH | Bliss Andrew | Director | 24.09.2026 | Verkauf | 40,10 | 100 | 4.010 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 24.09.2026 | Verkauf | 125,00 | 3.333 | 416.625 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 24.09.2026 | Verkauf | 120,00 | 1.416 | 169.920 | Form 4 |
| BLSH | Bliss Andrew | Director | 23.09.2026 | Verkauf | 40,22 | 59.976 | 2.412.031 | Form 4 |
| BLSH | Bliss Andrew | Director | 22.09.2026 | Verkauf | 40,79 | 108.200 | 4.413.056 | Form 4 |
| BLSH | Bliss Andrew | Director | 21.09.2026 | Verkauf | 40,20 | 76.953 | 3.093.888 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 21.09.2026 | Verkauf | 1,19 | 21.009 | 25.022 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 21.09.2026 | Verkauf | 106,61 | 1.416 | 150.960 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,29 | 5.840 | 644.112 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,31 | 2.920 | 322.100 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,30 | 6.968 | 768.561 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 17.09.2026 | Verkauf | 110,36 | 19.384 | 2.139.193 | Form 4 |
| BLBD | Sanfrey Jeffrey Scott | Chief Operating Officer | 16.09.2026 | Verkauf | 62,40 | 4.000 | 249.600 | Form 4 |
| BLND | Ghamsari Nima | HEAD OF BLEND | 14.09.2026 | Verkauf | 1,43 | 17.731 | 25.267 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 98,00 | 2.666 | 261.268 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 101,49 | 3.143 | 318.989 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 14.09.2026 | Verkauf | 100,78 | 2.010 | 202.559 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).